Discharge Destination as a Surrogate for Modified Rankin Scale Defined Outcomes at 3-and 12-Months Poststroke Among Stroke Survivors

被引:142
作者
Qureshi, Adnan I. [1 ]
Chaudhry, Saqib A.
Sapkota, Biggya L.
Rodriguez, Gustavo J.
Suri, M. Fareed K.
机构
[1] Univ Minnesota, Dept Neurol, Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN 55455 USA
来源
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION | 2012年 / 93卷 / 08期
基金
美国国家卫生研究院;
关键词
Nursing homes; Patient discharge; Rehabilitation; Stroke; ACUTE ISCHEMIC-STROKE; ACTIVATED FACTOR-VII; PLASMINOGEN-ACTIVATOR; CLINICAL-TRIALS; ALTEPLASE; THROMBOLYSIS; DESIGN;
D O I
10.1016/j.apmr.2012.02.032
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To determine the predictive value of discharge destination as a surrogate for defining unfavorable outcome at 3- and 12-months poststroke. Design: Analysis of the prospectively collected data from a randomized, placebo-controlled trial in patients with ischemic stroke presenting within 3 hours of symptom onset. Setting: Post hoc analysis of patients recruited in a clinical trial. Participants: Patients (N=530) discharged alive from the hospital after ischemic stroke. Interventions: Not applicable. Main Outcome Measures: Positive and negative predictive value and likelihood ratios of discharge destination for unfavorable outcome at 3- and 12-months poststroke defined by a Modified Rankin Scale (MRS) score of 2 to 6, 3 to 6, or 4 to 6. A likelihood ratio indicates how many times more (or less) likely a particular discharge destination is seen in patients with an unfavorable outcome compared with those without unfavorable outcome. Results: The positive predictive value of nursing home and rehabilitation facility discharges was highest for unfavorable outcome defined by an MRS score of 2 to 6 (95%) and rehabilitation facility (89%) at 3-months poststroke, respectively. The positive predictive value of rehabilitation facility/nursing home (90%) was also highest for unfavorable outcomes defined by an MRS score of 2 to 6 compared with those defined by MRS scores of 3 to 6 (79%) and 4 to 6 (57%). The positive likelihood ratio was highest for nursing home discharges (13; 95% confidence interval [CI], 4.1-41) followed by rehabilitation facility discharges for unfavorable outcome defined by an MRS score of 2 to 6 at 3-months poststroke (5.3; 95% Cl, 3.5-7.9). The negative likelihood ratio was the highest for home discharge for unfavorable outcome defined by an MRS score of 2 to 6 (4.5; 95% Cl, 3.4-6.1). A similar pattern was observed with unfavorable outcome defined using various thresholds at 12 months. Conclusions: Discharge destination can provide high predictive values and likelihood ratios for death and disability at 3-months poststroke, as defined by an MRS of score of 2 to 6.
引用
收藏
页码:1408 / 1413
页数:6
相关论文
共 32 条
[1]   Baseline NIH Stroke Scale score strongly predicts outcome after stroke - A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) [J].
Adams, HP ;
Davis, PH ;
Leira, EC ;
Chang, KC ;
Bendixen, BH ;
Clarke, WR ;
Woolson, RF ;
Hansen, MD .
NEUROLOGY, 1999, 53 (01) :126-131
[2]   Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study [J].
Albers, GW ;
Bates, VE ;
Clark, WM ;
Bell, R ;
Verro, P ;
Hamilton, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1145-1150
[3]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[4]   Outcomes validity and reliability of the modified Rankin scale: Implications for stroke clinical trials - A literature review and synthesis [J].
Banks, Jamie L. ;
Marotta, Charles A. .
STROKE, 2007, 38 (03) :1091-1096
[5]   Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals [J].
Bardach, NS ;
Zhao, SJ ;
Gress, DR ;
Lawton, MT ;
Johnston, SC .
STROKE, 2002, 33 (07) :1851-1856
[6]   Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial [J].
Bluhmki, Erich ;
Chamorro, Angel ;
Davalos, Antoni ;
Machnig, Thomas ;
Sauce, Christophe ;
Wahlgren, Nils ;
Wardlaw, Joanna ;
Hacke, Werner .
LANCET NEUROLOGY, 2009, 8 (12) :1095-1102
[7]   Patient Outcomes With Endovascular Embolectomy Therapy for Acute Ischemic Stroke A Study of the National Inpatient Sample: 2006 to 2008 [J].
Brinjikji, Waleed ;
Rabinstein, Alejandro A. ;
Kallmes, David F. ;
Cloft, Harry J. .
STROKE, 2011, 42 (06) :1648-1652
[8]   Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA Stroke Trial [J].
Broderick, JP ;
Lu, M ;
Kothari, R ;
Levine, SR ;
Lyden, PD ;
Haley, EC ;
Brott, TG ;
Grotta, J ;
Tilley, BC ;
Marler, JR ;
Frankel, M .
STROKE, 2000, 31 (10) :2335-2341
[9]   A systems approach to immediate evaluation and management of hyperacute stroke - Experience at eight centers and implications for community practice and patient care [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
ODonoghue, M ;
Barsan, W ;
Tomsick, T ;
Spilker, J ;
Miller, R ;
Sauerbeck, L ;
Farrell, J ;
Kelly, J ;
Perkins, T ;
McDonald, T ;
Rorick, M ;
Hickey, C ;
Armitage, J ;
Perry, C ;
Thalinger, K ;
Rhude, R ;
Schill, J ;
Becker, PS ;
Heath, RS ;
Adams, D ;
Reed, R ;
Klei, M ;
Hughes, A ;
Anthony, J ;
Baudendistel, D ;
Zadicoff, C ;
Rymer, M ;
Bettinger, I ;
Laubinger, P ;
Schmerler, M ;
Meiros, G ;
Lyden, P ;
Dunford, J ;
Zivin, J ;
Rapp, K ;
Babcock, T ;
Daum, P ;
Persona, D ;
Brody, M ;
Jackson, C ;
Lewis, S ;
Liss, J ;
Mahdavi, Z ;
Rothrock, J ;
Tom, T ;
Zweifler, R ;
Kobayashi, J .
STROKE, 1997, 28 (08) :1530-1540
[10]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011